NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Reset all filters
01 4NanoAlvand
02 9Incyte Corporation
03 22Novartis Pharmaceuticals Australia Pty Limited
04 14Novartis Pharmaceuticals Corporation
05 3Novartis South Africa (Pty) Ltd
06 3ORIFARM GROUP AS
Reset all filters
01 3Antic-calc Tablet
02 1CREAM;TOPICAL
03 3Cream
04 2Oral Solution
05 3TAB
06 5TABLET;ORAL
07 16Tablet
08 22Blank
Reset all filters
01 6Allowed
02 6Approved
03 5Authorized
04 3Originator
05 6RX
06 29Blank
Reset all filters
01 5JAKAFI
02 35Jakavi
03 1Jakavi 15 mg
04 1Jakavi 20 mg
05 1Jakavi 5 mg
06 1OPZELURA
07 2Opzelura
08 1Opzelura g
09 4Relata
10 4Strong
Reset all filters
01 22Australia
02 4Iran
03 3Norway
04 3South Africa
05 5Spain
06 6Sweden
07 6Switzerland
08 6USA
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Relata
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : JAKAFI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2011-11-16
Application Number : 202192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OPZELURA
Dosage Form : CREAM;TOPICAL
Dosage Strength : EQ 1.5% BASE
Packaging :
Approval Date : 2021-09-21
Application Number : 215309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Opzelura g
Dosage Form : Cream
Dosage Strength : 15mg
Packaging :
Approval Date : 30/01/2025
Application Number : 69443
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 15mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 27/12/2012
Application Number : 62126
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Jakavi
Dosage Form : Oral Solution
Dosage Strength : 5mg/ml
Packaging :
Approval Date : 27/03/2025
Application Number : 69722
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Jakavi
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 03/10/2014
Application Number : 20140311000017
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Jakavi
Dosage Form : Antic-calc Tablet
Dosage Strength : 15 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Jakavi
Dosage Form : Antic-calc Tablet
Dosage Strength : 20 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Jakavi
Dosage Form : Antic-calc Tablet
Dosage Strength : 5 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway